Fusion Pharmaceuticals (FUSN) Competitor Comparison
We are evaluating the key criteria listed to compare Fusion Pharmaceuticals (FUSN) against its competitors in the Biotechnology industry.
Market Capitalization
132 / 368Gross Profits
205 / 278Total Revenue
222 / 300EBITDA
194 / 337Free Cashflow
229 / 352Quick Ratio
68 / 357Earnings per Share
165 / 359Dividend yield
0 / 6Total Cash
161 / 358Performance 3 years
29 / 368Performance 5 years
122 / 368Performance 10 years
96 / 368Linearity 3 years
346 / 368Linearity 5 years
140 / 368Linearity 10 years
125 / 368Total Rank
132 / 368Dividend Rank
136 / 368Valuation Rank
54 / 368Piotroski Rank
281 / 368Muliplier Rank
348 / 368Total Cash - FUSN ranking 161 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.